The primary aim of this study was to evaluate the frequency and seasonality of norovirus infection in hospitalized Polish children under 5 years of age, and a secondary aim was to compare the clinical severity of norovirus and rotavirus disease. The prospective surveillance study was carried out from July 2009 through June 2010. Stool samples from 242 children hospitalized due to acute viral gastroenteritis were tested for rotavirus group A and adenovirus with commercial immunochromatographic test and for norovirus with EIA assay. Single norovirus infection was found in 35/242 (14.5%) patients and in a further 5 (2.1%) children as co-infection with rotavirus. Overall, norovirus was detected in 16.5% of stool specimens. Norovirus infections tended to peak from October to November and again from February to March. In autumn months and in February, the proportion of norovirus gastroenteritis cases was equal or even surpassed those of rotavirus origin. Both norovirus and rotavirus infections most commonly affected children between 12 and 23 months of age. The low-grade or no fever was significantly more common in children infected with norovirus (94.3%) compared to rotavirus cases (52.9%). Overall, norovirus gastroenteritis was less severe than rotavirus disease with regard to 20-point severity scale (p < 0.05). Noroviruses have emerged as a relevant cause of acute gastroenteritis in Polish children. There is a great need for introducing routine norovirus testing of hospitalized children with gastroenteritis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303077 | PMC |
http://dx.doi.org/10.1007/s10096-011-1321-z | DOI Listing |
Front Public Health
January 2025
Sanitation Teaching and Research Section, Department of Health Service, Naval Medical University, Shanghai, China.
Background: Norovirus remains a significant viral cause of waterborne and foodborne gastroenteritis outbreaks and epidemics worldwide. The burden of norovirus extends across different income settings.
Methods: Leveraging secondary data from the 2021 Global Burden of Diseases Study, our analysis spanned the period from 1990 to 2021 to assess the burden of norovirus-associated diseases (NADs).
Front Public Health
January 2025
Bavarian Health and Food Safety Authority (LGL), Munich, Germany.
[This corrects the article DOI: 10.3389/fpubh.2024.
View Article and Find Full Text PDFBiosens Bioelectron
January 2025
Tianjin Key Laboratory of Risk Assessment and Control Technology for Environment and Food Safety, Military Medical Sciences Academy, Academy of Military Sciences, Tianjin, 300050, China. Electronic address:
Norovirus is a globally prevalent pathogen that causes acute viral gastroenteritis across all age groups, characterized by its high infectivity and low infectious dose. Consequently, the development of rapid, sensitive, and accurate detection technologies for norovirus presents a significant challenge. In this study, we demonstrate a combination of CRISPR-Cas-based reactions with Pt@MOF-linked immunoassay-like assays.
View Article and Find Full Text PDFSci Total Environ
January 2025
Department of Environmental Health Sciences, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, United States of America; Organization for Public Health and Environment Management, Lalitpur, Nepal; Water & Energy Sustainable Technology (WEST) Center, University of Arizona, Tucson, AZ, United States of America; Center of Research Excellence in Wastewater based Epidemiology, Morgan State, Baltimore, MD, United States of America. Electronic address:
Given their abundance in human fecal samples, crAssphage and Pepper Mild Mottle Virus (PMMoV) are proposed as indicators for human enteric viruses. This study measured crAssphage and PMMoV in raw sewage samples (n = 24) between June 2014 and May 2015 from two wastewater treatment facilities in southern Arizona, USA. Both crAssphage and PMMoV were detected in nearly 100% of samples.
View Article and Find Full Text PDFNat Rev Microbiol
January 2025
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Human noroviruses (HuNoVs) are the leading cause of acute gastroenteritis worldwide in all age groups and cause significant disease and economic burden globally. To date, no approved vaccines or antiviral therapies are available to treat or prevent HuNoV illness. Several candidate vaccines are in clinical trials, although potential barriers to successful development must be overcome.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!